See more : FutureLand, Corp. (FUTL) Income Statement Analysis – Financial Results
Complete financial analysis of Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zhejiang Huahai Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Alnylam Pharmaceuticals, Inc. (ALNY) Income Statement Analysis – Financial Results
- Cardlytics, Inc. (CDLX) Income Statement Analysis – Financial Results
- 7GC & Co. Holdings Inc. (VII) Income Statement Analysis – Financial Results
- Wallbox N.V. (WBX) Income Statement Analysis – Financial Results
- China Communications Construction Company Limited (601800.SS) Income Statement Analysis – Financial Results
Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.huahaipharm.com
About Zhejiang Huahai Pharmaceutical Co., Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps. In addition, the company provides contract manufacturing and other services. Further, it is involved in import and export trade services. Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.31B | 8.27B | 6.64B | 6.49B | 5.39B | 5.09B | 5.00B | 4.09B | 3.50B | 2.58B | 2.30B | 2.01B | 1.83B | 1.02B | 927.97M | 801.43M | 706.98M | 557.26M | 423.25M | 391.13M | 303.04M | 187.38M | 177.81M | 136.01M |
| Cost of Revenue | 3.29B | 3.11B | 2.66B | 2.35B | 2.13B | 2.05B | 2.20B | 2.05B | 1.78B | 1.43B | 1.29B | 1.20B | 1.10B | 593.53M | 541.00M | 430.04M | 377.06M | 287.96M | 189.71M | 193.99M | 141.60M | 86.35M | 101.59M | 64.64M |
| Gross Profit | 5.02B | 5.15B | 3.99B | 4.13B | 3.26B | 3.04B | 2.80B | 2.04B | 1.72B | 1.15B | 1.01B | 811.16M | 724.31M | 429.32M | 386.97M | 371.39M | 329.92M | 269.30M | 233.54M | 197.14M | 161.44M | 101.03M | 76.21M | 71.37M |
| Gross Profit Ratio | 60.42% | 62.36% | 60.00% | 63.73% | 60.54% | 59.75% | 55.96% | 49.85% | 49.22% | 44.68% | 43.86% | 40.27% | 39.63% | 41.97% | 41.70% | 46.34% | 46.67% | 48.33% | 55.18% | 50.40% | 53.27% | 53.92% | 42.86% | 52.47% |
| Research & Development | 982.99M | 925.53M | 942.26M | 565.70M | 467.36M | 396.76M | 348.27M | 339.40M | 267.09M | 212.75M | 155.75M | 93.32M | 84.64M | 70.04M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 597.31M | 669.84M | 683.09M | 546.08M | 387.79M | 401.08M | 323.09M | 246.91M | 204.55M | 121.61M | 97.98M | 104.19M | 118.54M | 110.22M | 166.53M | 148.32M | 104.45M | 101.54M | 54.83M | 36.63M | 31.89M | 21.54M | 19.30M | 14.88M |
| Selling & Marketing | 1.29B | 1.24B | 1.18B | 996.33M | 960.54M | 1.29B | 904.65M | 614.72M | 448.12M | 274.47M | 150.99M | 83.22M | 49.28M | 42.54M | 27.16M | 23.45M | 17.46M | 17.61M | 12.99M | 12.68M | 6.53M | 3.95M | 2.95M | 1.42M |
| SG&A | 1.89B | 1.91B | 1.86B | 1.54B | 1.35B | 1.70B | 1.23B | 861.63M | 652.67M | 396.08M | 248.97M | 187.41M | 167.81M | 152.76M | 193.69M | 171.77M | 121.90M | 119.14M | 67.82M | 49.31M | 38.42M | 25.49M | 22.25M | 16.30M |
| Other Expenses | 1.02B | 587.67M | 525.25M | 433.09M | 326.40M | -318.00M | -11.93M | 62.26M | 36.10M | -8.69M | 15.20M | 47.37M | 1.18M | 31.66M | 26.59M | 2.78M | 4.68M | 7.45M | 8.05M | 7.97M | -4.32M | -622.26K | -1.45M | -846.53K |
| Operating Expenses | 3.90B | 3.43B | 3.33B | 2.54B | 2.14B | 2.25B | 1.90B | 1.51B | 1.18B | 806.75M | 580.28M | 419.04M | 396.80M | 318.10M | 202.36M | 177.61M | 127.75M | 123.23M | 71.15M | 51.15M | 39.86M | 26.35M | 23.07M | 17.76M |
| Cost & Expenses | 7.18B | 6.54B | 5.99B | 4.89B | 4.27B | 4.30B | 4.10B | 3.56B | 2.96B | 2.24B | 1.87B | 1.62B | 1.50B | 911.63M | 743.37M | 607.65M | 504.82M | 411.19M | 260.86M | 245.13M | 181.46M | 112.70M | 124.67M | 82.39M |
| Interest Income | 39.48M | 25.83M | 33.46M | 19.57M | 20.80M | 6.92M | 4.82M | 2.39M | 3.31M | 5.18M | 11.35M | 3.64M | 2.85M | 3.00M | 0.00 | -0.70 | -0.94 | 3.71M | 6.99M | 8.88M | 3.60M | 3.32M | 2.62M | 1.49M |
| Interest Expense | 237.76M | 220.02M | 166.34M | 135.33M | 224.66M | 139.81M | 56.42M | 36.44M | 20.02M | 25.54M | 31.45M | 27.71M | 14.94M | 3.61M | 8.56M | 23.76M | 15.30M | 4.46M | 260.32K | 141.36K | 633.94K | 5.13M | 3.92M | 3.25M |
| Depreciation & Amortization | 789.63M | 679.09M | 565.52M | 472.94M | 447.89M | 345.63M | 289.91M | 250.95M | 197.55M | 152.33M | 132.28M | 100.87M | 87.46M | 77.29M | 68.63M | 59.80M | 53.25M | 42.12M | 27.98M | 18.72M | 14.86M | 9.38M | 6.80M | 2.23M |
| EBITDA | 2.16B | 2.45B | 1.56B | 1.86B | 1.47B | 669.90M | 1.13B | 863.37M | 745.77M | 493.90M | 579.86M | 530.44M | 375.56M | 208.70M | 253.23M | 253.58M | 255.42M | 195.33M | 204.42M | 182.03M | 135.47M | 86.62M | 64.44M | 55.38M |
| EBITDA Ratio | 25.94% | 30.47% | 23.52% | 29.11% | 27.72% | 15.19% | 22.42% | 21.67% | 22.91% | 19.92% | 25.71% | 26.87% | 20.96% | 21.20% | 28.06% | 32.28% | 36.49% | 35.05% | 48.30% | 46.54% | 44.71% | 46.23% | 36.24% | 40.72% |
| Operating Income | 1.12B | 1.55B | 868.40M | 1.29B | 824.37M | 475.24M | 791.18M | 507.90M | 493.10M | 307.36M | 399.85M | 355.97M | 274.12M | 97.18M | 170.42M | 168.48M | 184.79M | 143.26M | 168.99M | 155.91M | 124.60M | 72.75M | 55.35M | 53.15M |
| Operating Income Ratio | 13.53% | 18.72% | 13.07% | 19.84% | 15.30% | 9.33% | 15.82% | 12.41% | 14.09% | 11.89% | 17.41% | 17.67% | 15.00% | 9.50% | 18.36% | 21.02% | 26.14% | 25.71% | 39.93% | 39.86% | 41.12% | 38.83% | 31.13% | 39.08% |
| Total Other Income/Expenses | -24.22M | -38.27M | -81.47M | -131.42M | -63.51M | -198.52M | -71.13M | 59.07M | 30.69M | -14.06M | 12.45M | 45.90M | -965.04K | 30.62M | 25.04M | -26.11M | -13.17M | 5.48M | 7.18M | 16.45M | -4.62M | -1.88M | -1.62M | -1.02M |
| Income Before Tax | 1.10B | 1.51B | 786.93M | 1.22B | 760.86M | 157.24M | 779.25M | 567.07M | 523.79M | 312.95M | 412.30M | 401.87M | 273.16M | 127.80M | 195.46M | 167.67M | 188.99M | 148.74M | 176.18M | 163.17M | 119.97M | 72.11M | 53.72M | 52.13M |
| Income Before Tax Ratio | 13.24% | 18.25% | 11.84% | 18.74% | 14.12% | 3.09% | 15.58% | 13.86% | 14.96% | 12.11% | 17.95% | 19.95% | 14.95% | 12.49% | 21.06% | 20.92% | 26.73% | 26.69% | 41.63% | 41.72% | 39.59% | 38.49% | 30.21% | 38.33% |
| Income Tax Expense | 283.07M | 332.89M | 306.28M | 220.76M | 154.04M | 22.34M | 155.66M | 110.17M | 87.07M | 56.22M | 48.88M | 63.37M | 59.07M | 34.27M | 31.07M | 17.81M | 56.95M | 38.68M | 47.19M | 44.04M | 40.68M | 21.51M | 10.84M | 17.43M |
| Net Income | 830.47M | 1.17B | 487.54M | 929.82M | 569.60M | 107.51M | 639.25M | 500.83M | 442.47M | 265.50M | 359.17M | 341.12M | 216.91M | 93.59M | 164.98M | 150.07M | 132.03M | 110.01M | 128.91M | 119.11M | 79.28M | 50.59M | 42.61M | 34.35M |
| Net Income Ratio | 10.00% | 14.13% | 7.34% | 14.34% | 10.57% | 2.11% | 12.78% | 12.24% | 12.64% | 10.27% | 15.64% | 16.93% | 11.87% | 9.15% | 17.78% | 18.72% | 18.67% | 19.74% | 30.46% | 30.45% | 26.16% | 27.00% | 23.96% | 25.26% |
| EPS | 0.57 | 0.81 | 0.34 | 0.64 | 0.39 | 0.08 | 0.46 | 0.37 | 0.33 | 0.20 | 0.28 | 0.28 | 0.18 | 0.08 | 0.14 | 0.12 | 0.11 | 0.09 | 0.10 | 0.08 | 0.05 | 0.05 | 0.04 | 0.03 |
| EPS Diluted | 0.57 | 0.80 | 0.34 | 0.64 | 0.39 | 0.08 | 0.46 | 0.37 | 0.33 | 0.20 | 0.28 | 0.28 | 0.18 | 0.08 | 0.14 | 0.12 | 0.11 | 0.09 | 0.10 | 0.08 | 0.05 | 0.05 | 0.04 | 0.03 |
| Weighted Avg Shares Out | 1.46B | 1.45B | 1.45B | 1.45B | 1.45B | 1.31B | 1.37B | 1.35B | 1.35B | 1.34B | 1.28B | 1.22B | 1.23B | 1.25B | 1.21B | 1.22B | 1.22B | 1.25B | 1.11B | 1.11B | 1.11B | 1.11B | 1.11B | 1.11B |
| Weighted Avg Shares Out (Dil) | 1.46B | 1.46B | 1.45B | 1.45B | 1.45B | 1.31B | 1.38B | 1.35B | 1.36B | 1.34B | 1.28B | 1.22B | 1.23B | 1.25B | 1.21B | 1.22B | 1.22B | 1.25B | 1.11B | 1.11B | 1.11B | 1.11B | 1.11B | 1.11B |
No news found for: 600521.SS
Source: https://incomestatements.info
Category: Stock Reports